79197642 - CAP GT

Information

• Trademark
• 79197642

• Source

• Serial Number

  79197642

• Registration Number

  5319386

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  July 11, 2016
  8 years ago

• Registration Date

  October 31, 2017
  7 years ago

• Transaction Date

  January 18, 2025
  a month ago

• Status Date

  May 17, 2024
  9 months ago

• Published for Opposition Date

  August 15, 2017
  7 years ago

• Location Date

  October 31, 2017
  7 years ago

• Status Code

  709

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  CORWIN, KEVIN

• Attorney Docket Number

  11168CP-6

  Attorney Name

  Miriam D. Trudell

  Law Office Assigned Location Code

  M30

• Owners

  • CEVEC Pharmaceuticals GmbH

Case File Statements

• GS0051: Medicines for the treatment and prevention of cancer, tumorous diseases, proliferative diseases, allergies, auto-immune diseases, inflammation, inflammatory diseases, infectious diseases, osteoporosis, graft versus host and host versus graft diseases, transplant rejection, coronary heart diseases, minimal residual diseases, restenosis, metabolic disorders, neurological disorders, diabetes, B cell malignancy, rheumatoid arthritis, immunological disorders, parasitic reactions, skin diseases, neurodegenerative diseases and cardio-vascular diseases, except thyreostatics and cough and cold preparations; pharmaceutical and veterinary products, preparations and reagents for the treatment and prevention of cancer, tumorous diseases, proliferative diseases, allergies, auto-immune diseases, inflammation, inflammatory diseases, infectious diseases, osteoporosis, graft versus host and host versus graft diseases, transplant rejection, coronary heart diseases, minimal residual diseases, restenosis, metabolic disorders, neurological disorders, diabetes, B cell malignancy, rheumatoid arthritis, immunological disorders, parasitic reactions, skin diseases, neurodegenerative diseases and cardio-vascular diseases, all afore mentioned goods except thyreostatics and cough and cold preparations; chemical, biological and biochemical preparations for the treatment and prevention of cancer, tumorous diseases, proliferative diseases, allergies, auto-immune diseases, inflammation, inflammatory diseases, infectious diseases, osteoporosis, graft versus host and host versus graft diseases, transplant rejection, coronary heart diseases, minimal residual diseases, restenosis, metabolic disorders, neurological disorders, diabetes, B cell malignancy, rheumatoid arthritis, immunological disorders, parasitic reactions, skin diseases, neurodegenerative diseases and cardio-vascular diseases, preparations and reagents for medical and veterinary purposes for the treatment and prevention of cancer, tumorous diseases, proliferative diseases, allergies, auto-immune diseases, inflammation, inflammatory diseases, infectious diseases, osteoporosis, graft versus host and host versus graft diseases, transplant rejection, coronary heart diseases, minimal residual diseases, restenosis, metabolic disorders, neurological disorders, diabetes, B cell malignancy, rheumatoid arthritis, immunological disorders, parasitic reactions, skin diseases, neurodegenerative diseases and cardio-vascular diseases, except cough and cold preparations, except chromatography chemicals and media, and except chemicals for use in separation and purification; diagnostic and analytical preparations for medical and veterinary purposes for the treatment and prevention of cancer, tumorous diseases, proliferative diseases, allergies, auto-immune diseases, inflammation, inflammatory diseases, infectious diseases, osteoporosis, graft versus host and host versus graft diseases, transplant rejection, coronary heart diseases, minimal residual diseases, restenosis, metabolic disorders, neurological disorders, diabetes, B cell malignancy, rheumatoid arthritis, immunological disorders, parasitic reactions, skin diseases, neurodegenerative diseases and cardio-vascular diseases; cultures of micro-organisms, protein arrays, synthetic polypeptides, nucleotide arrays, nucleic acid sequence, eukaryotic cell lines and eukaryotic cells for medical, veterinary and diagnostic purposes, except cough and cold preparations
• GS0011: Chemical, biological and biochemical products, preparations and reagents for scientific, research, laboratory, industrial and commercial purposes, except chromatography chemicals and media, and except chemicals for use in separation and purification; chemical, biological and biochemical products, preparations and reagents for researching and characterizing diseases except chromatography chemicals and media, and except chemicals for use in separation and purification; chemical, biological and biochemical products, preparations and reagents for scientific and medical research and drug development except chromatography chemicals and media, and except chemicals for use in separation and purification; chemical, biological and biochemical products, preparations and reagents for manufacturing drugs and pharmaceuticals, except chromatography chemicals and media, and except chemicals for use in separation and purification; micro-organisms, proteins, polypeptides, nucleotides, nucleic acids, eukaryotic cell lines and eukaryotic cells for scientific, research, laboratory, industrial and commercial purposes; all other than for medical or veterinary use
• GS0421: Scientific and industrial research, in particular in the fields of medicine, pharmacy, molecular biology, biotechnology and genetics; research and development of drugs, diagnostic and analytical preparations, therapy procedures and expression systems; scientific, technical and industrial consultancy, in particular in the field of research medicine, pharmacy, molecular biology, biotechnology and genetics; scientific and industrial research and development of eukaryotic cell lines, eukaryotic cells, micro-organisms, polypeptides, proteins, nucleotides, nucleic acids, for third parties for scientific, research, laboratory development, industrial and commercial purposes, in particular for use in the field of medicine, pharmacy, molecular biology, biotechnology and genetics, except services relating to capture and intermediate purification of proteins

Case File Event Statements

• 12/20/2016 - 8 years ago

  4 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 12/8/2016 - 8 years ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR

• 12/15/2016 - 8 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 12/15/2016 - 8 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 12/27/2016 - 8 years ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 12/28/2016 - 8 years ago

  6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 12/30/2016 - 8 years ago

  7 - REFUSAL PROCESSED BY MPU Type: RFRR

• 12/30/2016 - 8 years ago

  8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 1/20/2017 - 8 years ago

  9 - REFUSAL PROCESSED BY IB Type: RFNT

• 6/13/2017 - 7 years ago

  10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 6/13/2017 - 7 years ago

  12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 6/13/2017 - 7 years ago

  11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 8/2/2017 - 7 years ago

  16 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 8/15/2017 - 7 years ago

  17 - PUBLISHED FOR OPPOSITION Type: PUBO

• 8/15/2017 - 7 years ago

  18 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 8/18/2017 - 7 years ago

  19 - NOTIFICATION PROCESSED BY IB Type: GPNX

• 10/31/2017 - 7 years ago

  20 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 1/31/2018 - 7 years ago

  22 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR

• 8/17/2018 - 6 years ago

  26 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 7/11/2017 - 7 years ago

  13 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 7/26/2017 - 7 years ago

  14 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 8/2/2017 - 7 years ago

  15 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R

• 11/27/2017 - 7 years ago

  21 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 2/6/2018 - 7 years ago

  23 - FINAL DISPOSITION PROCESSED Type: FIMP

• 2/6/2018 - 7 years ago

  24 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS

• 3/30/2018 - 6 years ago

  25 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO

• 7/13/2021 - 3 years ago

  31 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 6/11/2021 - 3 years ago

  27 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 6/11/2021 - 3 years ago

  28 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 6/11/2021 - 3 years ago

  29 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Type: ECDR

• 6/11/2021 - 3 years ago

  30 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 7/13/2021 - 3 years ago

  32 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 7/13/2021 - 3 years ago

  33 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Type: ECDR

• 7/13/2021 - 3 years ago

  34 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 10/31/2022 - 2 years ago

  35 - COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Type: REM3

• 8/21/2023 - a year ago

  36 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR

• 8/21/2023 - a year ago

  41 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Type: ECDR

• 5/17/2024 - 9 months ago

  44 - CANCELLED SECTION 71 Type: C71T

• 1/18/2025 - a month ago

  46 - TOTAL INVALIDATION OF REG EXT PROTECTION CREATED Type: INTR

• 10/18/2024 - 4 months ago

  45 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP

• 8/21/2023 - a year ago

  39 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 8/21/2023 - a year ago

  37 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN

• 8/21/2023 - a year ago

  38 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 8/21/2023 - a year ago

  40 - TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED Type: EWOR

• 8/21/2023 - a year ago

  42 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 11/19/2023 - a year ago

  43 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP